Ceza Formulations Private Limited, a active private limited company, was established on 26 March 1999 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP1999PTC013421. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Narendra Kumar Dalawat (Director), Mimoh Paliwal (Director), Krishnakant Mundra (Director). Past directors included Naveen Khaitan, Narendra Kumar Dalawat, Mimoh Paliwal. It holds ₹7.80 M open charges and ₹1.03 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 236,Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452001.
U24232MP1999PTC013421
013421
26 March 1999
₹1.50 M
₹1.50 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Ceza Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narendra Kumar Dalawat | Director | 11 Jul 2016 | Current |
| Mimoh Paliwal | Director | 10 Nov 2014 | Current |
| Krishnakant Mundra | Director | 10 Nov 2014 | Current |
| Anil Kumar Vyas | Director | 13 Dec 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Nov 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2015 | Past |
| Pramod Abcsdd | Director | 18 Aug 2016 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ceza Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.59% increase. The company also saw a substantial improvement in profitability, with a 14.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ceza Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,800,000.00
₹10,250,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2018 | Others | ₹7.80 M | Open |
| 24 Oct 2016 | Others | ₹9.25 M | Satisfied |
| 25 Apr 2001 | State Bank Of Indore | ₹0.50 M | Satisfied |
| 25 Apr 2001 | State Bank Of India | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Ceza Formulations has a workforce of 8 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ceza Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceza Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ceza Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Ceza Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
The activity A charge with Others of Rs. 7.80 M registered on 17 Dec 2018 with Charge ID 100234068 was modified on 06 Mar 2019. was completed.
A charge registered on 24 Oct 2016 via Charge ID 100060752 with Others was fully satisfied on 05 Feb 2019. was recorded as a recent event.
A charge with Others amounted to Rs. 7.80 M with Charge ID 100234068 was registered on 17 Dec 2018. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 9.25 M with Charge ID 100060752 was registered on 24 Oct 2016. was documented.
The CIN of Ceza Formulations Private Limited is U24232MP1999PTC013421.
Ceza Formulations Private Limited is headquartered at 236,Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452001.
Ceza Formulations Private Limited was incorporated on 26 March 1999.
The current directors of Ceza Formulations Private Limited are
The primary industry of Ceza Formulations Private Limited is Manufacturing.
Ceza Formulations Private Limited is unlisted.
The authorized capital of Ceza Formulations Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Ceza Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX